Cytokinetics (CYTK) Interest Expenses (2016 - 2025)
Historic Interest Expenses for Cytokinetics (CYTK) over the last 12 years, with Q4 2024 value amounting to $8.9 million.
- Cytokinetics' Interest Expenses rose 2476.27% to $8.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $37.7 million, marking a year-over-year increase of 3319.08%. This contributed to the annual value of $37.7 million for FY2024, which is 3319.08% up from last year.
- According to the latest figures from Q4 2024, Cytokinetics' Interest Expenses is $8.9 million, which was up 2476.27% from $8.9 million recorded in Q3 2024.
- In the past 5 years, Cytokinetics' Interest Expenses ranged from a high of $12.7 million in Q2 2024 and a low of $2.7 million during Q1 2022
- Over the past 5 years, Cytokinetics' median Interest Expenses value was $5.5 million (recorded in 2021), while the average stood at $5.9 million.
- Per our database at Business Quant, Cytokinetics' Interest Expenses surged by 24846.15% in 2020 and then tumbled by 3114.34% in 2022.
- Quarter analysis of 5 years shows Cytokinetics' Interest Expenses stood at $4.0 million in 2020, then increased by 4.98% to $4.2 million in 2021, then surged by 67.31% to $7.1 million in 2022, then rose by 1.52% to $7.2 million in 2023, then rose by 24.76% to $8.9 million in 2024.
- Its Interest Expenses was $8.9 million in Q4 2024, compared to $8.9 million in Q3 2024 and $12.7 million in Q2 2024.